The European respiratory diseases market
Affordable, effective and innovative products drive sales.
Alzheimer's
Partnerships to personalise medicine
Peter Loescher has worked at the cutting edge of the pharmaceutical industry for 17 years. In the latter part of this period, for example, he headed Hoechst's division in Japan, where he was also spokesperson for the European pharmaceutical industry, negotiating with the Japanese government during its healthcare reform in 2002.
Earlier diagnosis for Alzheimer's
Christopher Pryce, PhD, describes a promising test that can predict the onset of Alzheimer's disease some two years earlier than currently available tests can determine. Furthermore, the test can be used in non-human primates in order to research the neurobiology and pharmacology of such neurodegenerative illnesses. Dr. Pryce is conducting preclinical research with this test together with…
Article • Focus topic
Alzheimer's disease: Demystifying dementia
Alzheimer's disease is probably the best-known form of neurodegenerative disease, which is usually characterised by a progressive loss of cognitive, emotional and social abilities. But what actually happens in the brain? Read more about current research and therapeutic approaches to this form of dementia.
Article • Information channel
Neurology: Let's get nervous
Neural networks are emblematic of complex systems, so it's no surprise that the field of neurology is eclectic and intricate, too. Main challenges for neurologists are therapies of and research on stroke, seizures, movement disorders such as Parkinson's disease, autoimmune disorders such as multiple sclerosis and dementias such as Alzheimer's disease.
